Zeria Pharmaceutical Co., Ltd.
Records under this name other than the patents Zeria Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Zeria Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,772,528 | Method for Producing Aminothiazole Derivative and Production Intermediate No holder on record Term ended Term ended Aug 23, 2025 · High confidence | Term ended | Term ended Aug 23, 2025 | High confidence |
| US 8,841,461 | Method for Producing Aminothiazole Derivative and Production Intermediate Term ended Term ended Aug 23, 2025 · High confidence | Term ended | Term ended Aug 23, 2025 | High confidence |
| US 9,000,163 | Method for producing aminothiazole derivative and production intermediate Term ended Term ended Aug 23, 2025 · USPTO record | Term ended | Term ended Aug 23, 2025 | USPTO record |
| US 8,501,772 | 3,8-diaminotetrahydroquinoline derivative Lapsed on the fee record Ended Aug 6, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2025 | USPTO record |
| US 7,417,124 | Antibodies specific for phosphorylation sites and screening methods using the same antibodies Term ended Term ended Jul 12, 2025 · USPTO record | Term ended | Term ended Jul 12, 2025 | USPTO record |
| US 8,329,913 | Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof Lapsed on the fee record Ended Dec 11, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2024 | USPTO record |
| US 8,299,255 | 3,8-diaminotetrahydroquinoline derivative Lapsed on the fee record Ended Oct 30, 2024 · USPTO record | Lapsed on the fee record | Ended Oct 30, 2024 | USPTO record |
| US 7,276,511 | Benzylamine derivative Term ended Term ended Aug 7, 2024 · USPTO record | Term ended | Term ended Aug 7, 2024 | USPTO record |
| US 6,747,022 | Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same Term ended Term ended Sep 3, 2022 · USPTO record | Term ended | Term ended Sep 3, 2022 | USPTO record |
| US 6,977,147 | Method of screening therapeutic or preventative agents for squamous epithelial cell carcinoma Formerly held Term ended Term ended Sep 17, 2021 · USPTO record | Term ended | Term ended Sep 17, 2021 | USPTO record |